Cipla, Ubio Biotech launches RT-PCR test kit 'ViraGen' for Covid in India
Drug
major Cipla on Thursday announced the commercialisation of its RT-PCR test kit 'ViraGen' for COVID-19 in India, in partnership with
Ubio Biotechnology Systems.
"This
launch will help address the current testing services and capacity issues while
reaffirming the company's ongoing expansion in the diagnostic space,"
Cipla said in a regulatory filing.
Cipla
will launch ViraGen test kit in the country in partnership with Ubio
Biotechnology Systems, the company stated.
The
company will commence supply of the COVID-19 virus detection kit from May 25,
2021.
Umang
Vohra, MD and Global CEO, Cipla, said, Cipla has been working relentlessly to
ensure accessibility to treatments in this fight against COVID-19. Guided by
our core purpose of 'Caring for Life', this partnership will enable us to reach
out to more people across the country at a crucial time like now. Read More
Comments
Post a Comment